Traws Pharma

TRAWNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$8.101 M

$0.53 -1.30%

Close of 7 Aug 2026

Revenue

$2.79M

#3400 by revenue

Earnings

$9.17M

#2067 by earnings

Shares outstanding

10,157,257

Latest filing cover page

P/E ratio

0.9

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#440ImmuronIMRN$8.32M
#441Kairos PharmaKAPA$8.26M
#442Traws PharmaTRAW$8.10M
#443Aprea TherapeuticsAPRE$8.05M
#444Ensysce BiosciencesENSC$7.99M

Where these numbers come from

Share counts and financials for Traws Pharma are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.